PROC logo

Procaps Group SA (PROC) Company Overview

Profile

Full Name:

Procaps Group S.A.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

Luxembourg

IPO:

December 9, 2019

Indexes:

Not included

Website:

http://www.procapsgroup.com

Description:

PROC (Procaps Group SA) is a pharmaceutical company based in Latin America. It specializes in developing and manufacturing health products, including dietary supplements and over-the-counter medications. PROC focuses on innovation and quality to improve health and wellness for consumers.

Key Details

Price

$0.91

Market Cap

$102.67 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$409.92 M(+0.04% YoY)

Annual EPS

$0.42(+140.78% YoY)

PE Ratio

1.75

Annual ROE

-4520.72%

Annual Debt To Equity

-303.86

Beta

0.55

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

May 12, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 6, 23 Brookline Capital
Hold

Screeners with PROC included

High Piotroski score stocks
Stocks below SMA 200
Stocks recommended to hold
Healthcare sector
All stocks
Small cap stocks
Specialty & Generic Drug Manufacturers industry
NASDAQ earnings calendar
Stocks cheaper than 1 dollar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.91
PROC price is $0.91

Price All-time High

$10.76
PROC price is currently -91.54% below its historical high of $10.76

Price Analysts Target

-
PROC price consensus analysts' forecast is unknown

Price Most Recent Change

0%
PROC {parameterFullLabel} has remained unchanged on Mar 7, 2025

Price YTD Change

-60.94%
PROC price is down -60.94% since January 1st

Price 3-Year Change

-89.81%
PROC price is down -89.81% over the past 3 years

Market cap

Market Cap

$102.67 M
PROC market capitalization is $102.67 million

Market Cap 3-Year Change

-89.81%
PROC market capitalization is down -89.81% over the past 3 years

Market Cap All-time High

$1.18 B
PROC market capitalization is currently -91.27% below its historical high of $1.18 billion

Market Cap Sector Rank

46.75%
PROC market capitalization is higher than 46.75% of companies in Healthcare sector

Technical

Beta

0.55
PROC beta is 0.55

200-day SMA

$1.98
PROC price is currently -53.98% below its 200-day simple moving average

14-day RSI

32.23
PROC 14-day relative strength index is 32.23

30-day Relative Volume

0.02
PROC 30-day relative volume is 0.02

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$409.92 M
PROC annual revenue is $409.92 million

Annual Revenue Analysts Estimate

$424.15 M
PROC annual revenue is currently -3.35% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+0.04%
PROC annual revenue is up +0.04% year-on-year

Annual Revenue Sector Rank

73.64%
PROC annual revenue is higher than 73.64% of companies in Healthcare sector

Profit

Annual Gross Profit

$239.57 M
PROC annual gross profit is $239.57 million

Annual Gross Margin

58.44%
PROC annual gross profit margin is 58.44%

Annual Operating Profit

$40.09 M
PROC annual operating income is $40.09 million

Annual Operating Margin

9.78%
PROC annual operating profit margin is 9.78%

Annual Net Income

$42.54 M
PROC annual net profit is $42.54 million

Annual Net Margin

10.38%
PROC annual net profit margin is 10.38%

EPS

Annual EPS

$0.42
PROC annual earnings per share is $0.42

Annual EPS Analysts Estimate

-
PROC annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+140.78%
PROC annual earnings per share is up +140.78% year-on-year

Annual EPS Sector Rank

86.12%
PROC annual earnings per share is higher than 86.12% of companies in Healthcare sector

ROA & ROE

Annual ROA

9.22%
PROC annual return on assets is 9.22%

Annual ROE

-4520.72%
PROC annual return on equity is -4520.72%

EBIT & EBITDA

Annual EBIT

$78.47 M
PROC annual earnings before interest & taxes is $78.47 million

Annual EBITDA

$95.32 M
PROC annual EBITDA is $95.32 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

1.75
PROC price to earnings ratio is 1.75

PE Ratio Sector Rank

3.94%
PROC price to earnings ratio is higher than 3.94% of companies in Healthcare sector

PB Ratio

PB Ratio

2.61
PROC price to book ratio is 2.61

PB Ratio Sector Rank

66.97%
PROC price to book ratio is higher than 66.97% of companies in Healthcare sector

PS Ratio

PS Ratio

0.25
PROC price to sales ratio is 0.25

PS Ratio Sector Rank

8.6%
PROC price to sales ratio is higher than 8.6% of companies in Healthcare sector

Enterprise value

Enterprise Value

$375.03 M
PROC enterprise value is $375.03 million

Enterprise Value Sector Rank

64.4%
PROC enterprise value is higher than 64.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.04
PROC EV/EBITDA is 3.04

EV/EBITDA Sector Rank

77.32%
PROC EV/EBITDA is higher than 77.32% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.81
PROC annual current ratio is 0.81

Annual Quick Ratio

0.54
PROC annual quick ratio is 0.54

Leverage

Annual Debt To Equity

-303.86
PROC annual debt to equity ratio is -303.86

Annual Interest Coverage Ratio

3.05
PROC annual interest coverage ratio is 3.05

Risk & Stability

Piotroski F-Score

6
PROC piotroski f-score is 6

Altman Z-Score

0.21
PROC altman z-score is 0.21

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$460.19 M
PROC annual total assets is $460.19 million

Annual Non Current Assets

$162.74 M
PROC annual long term assets is $162.74 million

Annual Current Assets

$297.44 M
PROC annual total current assets is $297.44 million

Annual Cash & Cash Equivalents

$43.00 M
PROC annual cash & cash equivalents is $43.00 million

Equity

Annual Book Value

-$941.00 K
PROC annual book value is -$941.00 thousand

Annual Working Capital

-$70.93 M
PROC annual working capital is -$70.93 million

Liabilities

Annual Total Liabilities

$462.06 M
PROC annual total liabilities is $462.06 million

Annual Total Long Term Liabilities

$93.69 M
PROC annual total long term liabilities is $93.69 million

Annual Current Liabilities

$368.37 M
PROC annual total current liabilities is $368.37 million

Annual Accounts Payable

$81.48 M
PROC annual accounts payable is $81.48 million

Debt

Annual Total Debt

$285.94 M
PROC annual total debt is $285.94 million

Annual Total Debt 1-Year Change

+12.85%
PROC annual total debt is up +12.85% year-on-year

Annual Long Term Debt

$28.41 M
PROC annual long term debt is $28.41 million

Annual Short Term Debt

$257.52 M
PROC annual short term debt is $257.52 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$369.83 M
PROC annual total expenses is $369.83 million

Annual Operating Expenses

$199.48 M
PROC annual total operating expenses is $199.48 million

Annual Cost Of Goods Sold

$170.35 M
PROC annual cost of goods sold is $170.35 million

Annual SGA

$199.48 M
PROC annual SGA is $199.48 million

Annual D&A

$16.84 M
PROC annual depreciation & amortization is $16.84 million

Annual Interest Expense

$25.76 M
PROC annual interest expense is $25.76 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$14.11 M
PROC annual cash flow from operations is $14.11 million

Annual CFO 1-Year Change

-62.19%
PROC annual cash flow from operations is down -62.19% year-on-year

Annual CFI

-$28.83 M
PROC annual cash flow from investing activities is -$28.83 million

Annual CFI 1-Year Change

-21.62%
PROC annual cash flow from investing activities is down -21.62% year-on-year

Annual CFF

-$13.63 M
PROC annual cash flow from financing activities is -$13.63 million

Annual CFF 1-Year Change

-123.48%
PROC annual cash flow from financing activities is down -123.48% year-on-year

Free CashFlow

Annual FCF

-$17.47 M
PROC annual free cash flow is -$17.47 million

Annual FCF 1-Year Change

-236.71%
PROC annual free cash flow is down -236.71% year-on-year

CAPEX

Annual CAPEX

$31.57 M
PROC annual capital expenditures is $31.57 million

Annual CAPEX 1-Year Change

+28.75%
PROC annual capital expenditures is up +28.75% year-on-year

Institutional Ownership

Similar stocks

GALT logo
Galectin Therapeutics (GALT)
Baird Medical Investment Holdings Limited (BDMD)
ORMP logo
Oramed Pharmaceuticals (ORMP)
BMEA logo
Biomea Fusion (BMEA)
CRBU logo
Caribou Biosciences (CRBU)
ANRO logo
Alto Neuroscience (ANRO)
VTYX logo
Ventyx Biosciences (VTYX)
XBIT logo
XBiotech (XBIT)
MIST logo
Milestone Pharmaceuticals (MIST)

FAQ

  • What is the ticker symbol for Procaps Group SA?
  • Does Procaps Group SA pay dividends?
  • What sector is Procaps Group SA in?
  • What industry is Procaps Group SA in?
  • What country is Procaps Group SA based in?
  • When did Procaps Group SA go public?
  • Is Procaps Group SA in the S&P 500?
  • Is Procaps Group SA in the NASDAQ 100?
  • Is Procaps Group SA in the Dow Jones?
  • When was Procaps Group SA's last earnings report?
  • When does Procaps Group SA report earnings?
  • Should I buy Procaps Group SA stock now?

What is the ticker symbol for Procaps Group SA?

The ticker symbol for Procaps Group SA is NASDAQ:PROC

Does Procaps Group SA pay dividends?

No, Procaps Group SA does not pay dividends

What sector is Procaps Group SA in?

Procaps Group SA is in the Healthcare sector

What industry is Procaps Group SA in?

Procaps Group SA is in the Drug Manufacturers - Specialty & Generic industry

What country is Procaps Group SA based in?

Procaps Group SA is headquartered in Luxembourg

When did Procaps Group SA go public?

Procaps Group SA's initial public offering (IPO) was on December 9, 2019

Is Procaps Group SA in the S&P 500?

No, Procaps Group SA is not included in the S&P 500 index

Is Procaps Group SA in the NASDAQ 100?

No, Procaps Group SA is not included in the NASDAQ 100 index

Is Procaps Group SA in the Dow Jones?

No, Procaps Group SA is not included in the Dow Jones index

When was Procaps Group SA's last earnings report?

Procaps Group SA's most recent earnings report was on Feb 5, 2025

When does Procaps Group SA report earnings?

The date for Procaps Group SA's next earnings report has not been announced yet

Should I buy Procaps Group SA stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions